الملاحظات

Member for: 2 days (since Jun 29)
Type: Registered user
Full name:
Location:
Website: https://www.selleckchem.com/products/MK-1775.html
About: Early on Tumour Shrinking and also Detail of Reply within the Second-Line Strategy to KRAS exon2 Wild-Type Metastatic Intestines Cancer malignancy: A good Exploratory Investigation Randomized Period A couple of Test Comparing Panitumumab and Bevacizumab along with FOLFIRI (WJOG6210G).

Activity by beliefpanda09

Score: 0 points
Questions: 0
Answers: 0
Comments: 0
Voted on: 0 questions, 0 answers
Gave out: 0 up votes, 0 down votes
Received: 0 up votes, 0 down votes

3.3k questions

10.4k answers

14.1k comments

2.6m users

مرحبًا بك إلى Zamericanenglish Q&A، حيث يمكنك طرح الأسئلة وانتظار الإجابة عليها من المستخدمين الآخرين.
add
...